期刊文献+

危重患儿血清细胞因子C反应蛋白乳酸测定及临床意义 被引量:3

The detection and clinic value of cytokine、c-react protein and lactate in critically ill children
原文传递
导出
摘要 目的研究危重患儿血清白细胞介素-1β(IL-1β)、IL-6、肿瘤坏死因子-α(TNFα-)、C反应蛋白(CRP)、乳酸(LAC)的变化。方法检测48例危重患儿,20例非危重患儿血清IL-1β、IL-6、TNFα-、CRP、LAC的水平。结果危重患儿血清IL-1β、IL-6、TNFα-、CRP、LAC的水平明显高于非危重患儿,且危重患儿中SIRS组明显高于非SIRS组、感染组明显高于非感染组,差异有显著性。结论血中IL-1β、IL-6、TNFα-、CRP、LAC参与危重病的发生发展过程,可作为危重病发生多器官功能不全的警示参数及诊断指标,并可预测危重患儿的预后及转归。 Objective To study the change of interleukin-1β(IL-1β), IL-6, tumor necrosis factor-α (TNF-α), CRP, LAC in the serum of critically ill children. Methods The levels of IL-1β, IL-6, TNF-α, CRP, LAC in 48 critically ill children and 20 children without critical illness were detected. Results The levels of IL-1β, IL-6, TNF-α, CRP in chidren with critical illness were higher than that in those without critical illness, the group with SIRS was higher than that without SIRS and the group with infection was higher than that without infection respectively, the differences were significant. Conclusion IL-1β, IL-6, TNF-α, CRP, LAC are related to the development and deterioration of critical illness. They can be regarded as alarm sterms or dig- nosis standard of MOF, and be used to evaluate the prognosis.
出处 《中国小儿急救医学》 CAS 2006年第2期134-136,共3页 Chinese Pediatric Emergency Medicine
关键词 危重症 细胞因子 C反应蛋白 乳酸 Critically ill Cytokine C-react protein Lactate
  • 相关文献

参考文献4

二级参考文献13

  • 1中华医学会儿科学会急救学组.小儿危重病例评分法(草案)[J].中华儿科杂志,1995,33(6):371-371.
  • 2中华医学会儿科学会急救学组.第四届全国小儿急救医学研讨会纪要[J].中华儿科杂志,1995,33:370-370.
  • 3Bone RC, Balk RA, Cerra FB, et al. Definition for sepsis and organ failure and guidelined for the use of innovation therapies in sepsis. The ACCP/SCCM Consensus Committee American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992, 101:1644- 1655.
  • 4Hayden WR. Sepsis terminology in pediatrics. J pediatr, 1994, 124:657 - 658.
  • 5Khalids A Khabar,Mahmound A Elbarbary,Fareed Khouqeer.Circulating endotoxine and cytokines after cardiopulmonary bypass:differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndrome.Clinic Immunol Immunopathology,1997,97—103.
  • 6Old LJ. Tumor necrosis factor. Polypetide mediator network [J]. Nature, 1987,326(6111): 330-331.
  • 7许峰,杨锡强,卢仲毅,匡凤格,彭崇谦,雷培芸,杨仁仪,赵平.危重儿糖代谢紊乱时胰岛素拮抗和胰岛素受体变化[J]实用儿科临床杂志,1993(04).
  • 8Endo S,Kasai T,Inana K.Eveluation of procalcitonin in levels in patients with systemic inflammatory response syndrome as the diagnosis of infection and the severity of illness〔J〕[].Kansenshogaku ZasshiKansenshogaku Za.1999
  • 9樊寻梅,宋国维.小儿危重病例评分法(草案)临床应用的评价[J].中华儿科杂志,1998,36(10):579-582. 被引量:131
  • 10汤定华,张宇鸣,张国琴,黄绮薇,张育才,戎群芳.儿科加强医疗病房全身炎症反应综合征和多器官功能不全综合征的临床分析[J].中华儿科杂志,1998,36(10):583-585. 被引量:56

共引文献73

同被引文献21

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部